Andrew Reardon - 15 Feb 2024 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Signature
/s/ Andrew Reardon
Issuer symbol
LGND
Transactions as of
15 Feb 2024
Net transactions value
-$44,267
Form type
4
Filing time
16 Feb 2024, 20:10:38 UTC
Previous filing
04 Jan 2024
Next filing
29 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Tax liability $44,267 -593 -3.8% $74.65 14,997 15 Feb 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.